[ad_1]
The government was found to be negotiating overseas purchases for five products that have entered phase 3 clinical trials among new vaccines against coronavirus infection (Corona 19).
Joon-wook Kwon, head of the second division of the Central Defense Countermeasures Headquarters (Bang Dae-bon), said at a regular briefing held at the Centers for Disease Control and Prevention in Osong, Chungbuk, on the day 17. Excluding duplicates, there are about 10 vaccines, and 5 of them are objective, excluding cases where data or information from clinical trials is insufficient. “
He continued: “Among the five, the situation in which the opinions of the advisory committee were gathered that each purchase in a time difference is necessary.”
Previously, the government held a vaccine introduction advisory committee comprised of experts to review and discuss information on the safety and efficacy, price, transportation, and delivery time of the overseas vaccines currently being developed.
When the Corona 19 vaccine is developed, the government will provide 10 million people through the COVAX facility, an international project for the joint purchase and distribution of vaccines, and 20 million people through individual negotiations with global drug development companies. vaccinations It is approached as a “two-way strategy” to insure.
In this regard, the deputy director of Kwon said: “The process of selective purchasing through the facilitation of COVAX and the purchase of vaccines through consultation with individual pharmaceutical companies is progressing to the end. 19 Vaccine) We are pursuing the goal of completing the vaccination for those who receive the first vaccine ”.
He said: “The advisory committee has gathered some opinions on the vaccination strategy and who will be given priority.” I’m doing everything. “
Deputy CEO Kwon did not comment on the details of the negotiations.
He told a question about the vaccines from US pharmaceutical companies Pfizer and Modena, who recently showed positive clinical results, “are already in bilateral negotiations, but details related to the negotiations are currently unclear. At the beginning of December, there will be the opportunity to talk about the current status of the contract and the amount to be insured ”.
Regarding the issue of ensuring the safety of vaccines, the deputy director of Kwon said: “If the approval period of the global vaccine developers reported in their countries or the EU Food and Drug Administration is as soon as possible, it could be done in december. “The actual vaccination is possible from January,” he said. “It is reasonable that the authorities confirm and begin (inoculation) additional side effects of 500,000 to 1 million cases.”
Regarding the situation of vaccine development by domestic companies, he said, “Korean manufacturers are also putting all their efforts in developing treatments and vaccines,” he said. If it’s complete, I’ll buy it. Even if they don’t get the vaccine, they will buy it. “
The deputy director of Kwon also said that it is important to follow quarantine rules until the vaccine is released, and the cooperation of individual citizens in the quarantine was repeatedly requested.
“This winter is the last winter that goes without a vaccine,” he said. “We can see the future from the news about the development of the vaccine, but we still don’t have a vaccine in our hands, only clinical studies have come out.” There is nothing that changes the world immediately. “
He continued: “Still, keeping the quarantine rules thoroughly is the most effective and only way to deter the COVID-19 epidemic.” “Please take a careful step by step to the end so as not to injure yourself by being vigilant on the way downhill in response to Corona 19.”
(2)
[ad_2]
